Neuroendocrine Tumor
Cancer
Neuroendocrine Tumor is treated with 2 medications in our database, including Lutathera, NETSPOT. 2 of these have manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Novartis, Advanced Accelerator Applications. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Neuroendocrine Tumor treatment below.
What help exists for Neuroendocrine Tumor
2
drugs indexed
1
with copay cards
1
with patient assistance
2
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Neuroendocrine Tumor
2 total🎟 = copay card · 💙 = patient assistance program
Prior authorization patterns for Neuroendocrine Tumor drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
Grants for Neuroendocrine Tumor patients
5 total · 2 open- open
Afinitor Everolimus Copay Assistance Program
Covers: financial assistance
- open
Novartis Patient Assistance Foundation (NPAF)
Novartis
Covers: financial assistance
- unknown
CNETS Financial Support
CNETS
Covers: caregiver support, transportation, financial assistance
- closed
The CureNET Project Patient Grant
Covers: financial assistance
- closed
The CureNET Project Patient Grant
Neuroendocrine Cancer Foundation
Covers: financial assistance